U.S. West Texas Intermediate crude oil futures are putting in a mixed performance on Friday on low post-holiday volume. Earlier in the session, the U.S. futures contract fell more than 1% amid concerns about oversupply and doubts about a vaccine to end the coronavirus pandemic, but at the mid-session, the market is trading higher, putting it on course for a fourth straight week of gains ahead of an OPEC+ meeting early next week.

Vaccine Issues Encouraging Profit-Taking

In a slow news week, traders were once again focusing on a coronavirus vaccine, but this time, they appear to be booking profits after a big price jump as several scientists have sounded doubts over how robust the results of trials from AstraZeneca were.

Earlier in the week, both oil benchmarks jumped about 6% after AstraZeneca announced that its COVID-19 vaccine could be up to 90% effective, adding to successful trial results of Pfizer and Moderna Inc under development in the fight to end the worst pandemic in a century.

However, former pharmaceutical executives in the U.S. raised questions this week over the Oxford-AstraZeneca vaccine candidate. “We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.

US Crude Stockpiles Fall Unexpectedly, Gasoline Builds:  EIA

U.S. crude oil inventories fell last week, as well as distillate stocks, while gasoline stockpiles rose sharply, the U.S. Energy…


Via Oilprice.com

READ ALSO  U.S. Shale Drillers Begin To Hedge Oil Price Production
  • bitcoinBitcoin (BTC) $ 36,299.00
  • ethereumEthereum (ETH) $ 1,165.81
  • tetherTether (USDT) $ 0.999383
  • litecoinLitecoin (LTC) $ 142.42
  • bitcoin-cashBitcoin Cash (BCH) $ 480.25